Femtobiomed (XKRX:327610) FCF Yield % : -3.46 (As of Jun. 25, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Femtobiomed's Trailing 12-Month Free Cash Flow is ₩-2,441.6 Mil, and Market Cap is ₩70,654.0 Mil. Therefore, Femtobiomed's FCF Yield % for today is -3.46%.

The historical rank and industry rank for Femtobiomed's FCF Yield % or its related term are showing as below:

XKRX:327610' s FCF Yield % Range Over the Past 10 Years
Min: -40.43 Med: -3.26 Max: -1.01
Current: -3.46

During the past 6 years, the highest FCF Yield % of Femtobiomed was -1.01%. The lowest was -40.43%. And the median was -3.26%.

XKRX:327610's FCF Yield % is ranked better than
75.26% of 1548 companies
in the Biotechnology industry
Industry Median: -14.645 vs XKRX:327610: -3.46

Femtobiomed's FCF Margin % for the quarter that ended in Dec. 2023 was -731.11%.

Femtobiomed FCF Yield % Historical Data

The historical data trend for Femtobiomed's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed FCF Yield % Chart

Femtobiomed Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-5.17

-2.76

-2.42

-4.44

-5.23

Femtobiomed Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
FCF Yield %	Get a 7-Day Free Trial			-5.17	-2.76	-2.42	-4.44	-5.23

Competitive Comparison of Femtobiomed's FCF Yield %

For the Biotechnology subindustry, Femtobiomed's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Femtobiomed's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Femtobiomed's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Femtobiomed's FCF Yield % falls into.

Femtobiomed FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Femtobiomed's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-2441.567	/	46710.6164
	=	-5.23%

Femtobiomed's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2441.567	*	1	/	46710.6164
	=	-5.23%

Femtobiomed FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Femtobiomed FCF Yield % Related Terms

Thank you for viewing the detailed overview of Femtobiomed's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Femtobiomed (XKRX:327610) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487

Website

https://www.femtobiomed.com

Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed (XKRX:327610) Headlines

No Headlines